Compare DCTH & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DCTH | TLRY |
|---|---|---|
| Founded | 1988 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.4M | 533.5M |
| IPO Year | 2015 | 2018 |
| Metric | DCTH | TLRY |
|---|---|---|
| Price | $14.42 | $2.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 10 |
| Target Price | ★ $24.00 | $5.89 |
| AVG Volume (30 Days) | 251.9K | ★ 3.7M |
| Earning Date | 11-03-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.53 | 55.69 |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.61 | $20.15 |
| Revenue Next Year | $24.27 | $5.32 |
| P/E Ratio | $368.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.12 | $0.77 |
| 52 Week High | $17.42 | $15.70 |
| Indicator | DCTH | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 19.22 |
| Support Level | $14.26 | N/A |
| Resistance Level | $16.51 | $4.91 |
| Average True Range (ATR) | 0.51 | 0.17 |
| MACD | -0.06 | -0.04 |
| Stochastic Oscillator | 17.28 | 2.12 |
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.